DNA Damage and Repair Mechanisms Triggered by Exposure to Bioflavonoids and Natural Compounds by Goodenow, Donna et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







DNA Damage and Repair 
Mechanisms Triggered by 
Exposure to Bioflavonoids and 
Natural Compounds
Donna Goodenow, Kiran Lalwani and Christine Richardson
Abstract
Eukaryotic cells use homologous recombination (HR), classical end-joining 
(C-NHEJ), and alternative end-joining (Alt-EJ) to repair DNA double-strand 
breaks (DSBs). Repair pathway choice is controlled by the activation and activity 
of pathways specific proteins in eukaryotes. Activity may be regulated by cell cycle 
stage, tissue type, and differentiation status. Bioflavonoids and other environmen-
tal agents such as pesticides have been shown to biochemically act as inhibitors of 
topoisomerase II (Top2). In cells, bioflavonoids directly lead to DNA double-strand 
breaks through both Top2-dependent and independent mechanisms, as well as 
induce DNA damage response (DDR) signaling, and promote alternative end-join-
ing and chromosome alterations. This chapter will present differences in expression 
and activity of proteins in major DNA repair pathways, findings of Top2 inhibi-
tion by bioflavonoids and cellular response, discuss how these compounds trigger 
alternative end-joining, and conclude with implications for genome  instability and 
human disease.
Keywords: environmental compounds, bioflavonoids, DNA double-strand breaks, 
topoisomerase II, DNA break repair, genome instability
1. Introduction
The faithful repair of deoxyribonucleic acid (DNA) lesions is central to the 
maintenance of genomic integrity [1]. DNA double-strand breaks (DSBs) occur 
during normal developmental processes including meiosis, mating-type switch-
ing, V(D)J recombination, antigen receptor gene rearrangement, and also through 
normal activity of topoisomerase II (Top2) [2–5]. DSBs also result from exposure to 
exogenous sources such as ionizing radiation (IR), reactive oxygen species, and che-
motherapeutic agents including inhibitors of Top2 [6–9]. Aberrant repair of DSBs 
may be mutagenic and result in cell lethality or promote oncogenic transformation. 
Repair of DSBs in eukaryotes occurs by either homology-dependent or homology-
independent (also known as end-joining or illegitimate) mechanisms [10–13]. 
In yeast, homology-dependent repair predominates over end-joining [10, 14]. In 
mammalian cells, direct examination of repair products has demonstrated the 
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predominant use of end-joining [13]. The majority of studies generate targeted 
DSBs by endonucleases or lasers, and introduce artificial repair substrates into the 
system [15]. However, exposure to natural compounds can lead to multiple DSBs 
in a variety of chromatin regions and contexts [16–20]. Understanding how cells 
respond to these compounds and repair damage caused by them has important 
implications for genome stability.
Bioflavonoids are natural compounds in soy, fruits, vegetables, tea, coffee, 
and wine, and contained in energy drinks and dietary supplements [21–24]. 
Bioflavonoids are also in pesticides and flame retardants [25–27]. Bioflavonoids 
inhibit the enzyme topoisomerase II (Top2) to promote DSBs, and recent studies 
have elucidated the cellular mechanisms used to repair the DSBs induced by biofla-
vonoids [16, 28, 29]. This chapter will discuss cell type differences in expression and 
activity of proteins in major DNA repair pathways, summarize findings of cellular 
response to bioflavonoids and Top2 inhibition, discuss how these compounds trig-
ger alternative end-joining, and conclude with implications for genome instability 
and human disease.
1.1 DNA double-strand break repair
There are three main repair pathways to deal with DNA double-strand breaks 
(DSBs) in eukaryotic cells. These include classic nonhomologous end-joining 
(C-NHEJ) (Figure 1A) that modifies and allows for ligation of ends, alternative 
end-joining (Alt-EJ) that generates short overhangs or exposes small regions of 
homology via resection to promote ligation of ends (Figure 1B), and homologous 
recombination (HR) that uses a homologous sister chromatid, chromosome, or 
other sequence as a template to direct repair synthesis (Figure 1C) [10, 30]. HR 
is the most accurate using a homologous template as a donor sequence. DSBs are 
recombination initiators in both meiotic and mitotic cells [31–33]. However, HR 
has the most protein involvement, is tightly regulated, largely limited to S phase, 
and kinetically slow. C-NHEJ is utilized throughout the cell cycle and is kinetically 
fast. Alt-EJ is less well characterized than the other two and considered a backup 
repair mechanism when HR or C-NHEJ cannot be used. For a DSB to be repaired by 
HR or either of the end-joining pathways, damage must first be sensed, then signal 
transduction pathways must be activated for the DNA damage response (DDR) 
to bring proteins necessary for repair to the site(s) of damage. Indirect signaling 
and direct repair protein levels along with histone modifications appear to direct 
DSB repair pathway selection [34–37]. Despite decades of extensive study of DSB 
repair, scientists continue to identify and characterize new factors mechanistically 
involved in DSB end processing, repair itself, as well as pathway choice [38].
1.2 End-joining pathway choice
Repair of DNA DSBs by C-NHEJ or Alt-EJ is characterized by ligation of two 
DSB ends in close proximity to each other (Figure 1A and B). Initial binding of the 
Ku70–80 heterodimer competes with poly(ADP-ribose) polymerase 1 (PARP1) 
for binding to the DSB. If Ku70–80 binds first there is minimal end processing and 
C-NHEJ is used [39–44]. For C-NHEJ, DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs) is recruited to the Ku complex. DNA-PKcs can determine if 
the ends are blunt, as from a nuclease cleavage or from RAG during V(D)J recom-
bination, or if there are overhangs or protein/group adducts. If the break is clean, 
DNA-PKcs recruits XRCC4-XLF and LigaseIV, and these proteins work together to 
ligate the DNA ends [39, 42, 45]. However, if there is an overhang or proteins are 
attached to the break site, DNA-PKcs recruits the ARTEMIS complex for processing. 
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ARTEMIS can release protein groups and with its nuclease activity to digest the DSB 
ends until they are blunt to facilitate ligation of the ends [46].
If PARP1 binds to the DSB before Ku70–80, it immediately adds branched 
poly(ADP-ribose) (PAR) groups to itself and histones in close proximity. The 
branched PAR recruit the Mre11-Rad50-Nbs1 (MRN) complex to process the ends 
and proceed by HR or Alt-EJ. Alt-EJ seems to act as a salvage repair mechanism for 
when HR and C-NHEJ are blocked. It is likely that Alt-EJ occurs when processing 
for HR has started following PARP1 binding to the break first, Ku70–80 is depleted, 
because the DSB ends have proteins bound to block template invasion, or the cell is 
in G1 phase of the cell cycle no homologous template is readily available for repair. 
Alt-EJ involves MRN and CtIP to resect the DSB ends in a 3′ to 5′ fashion, termed 
short range end resection, of 5–25 nucleotides to create short DNA overhangs with 
small regions of homology. Polymerase θ is utilized in Alt-EJ. After processing, 
XRCC1 and LigaseIII act in a complex to ligate the ends and remove the overhanging 
bases. Alt-EJ is more mutagenic than HR or C-NHEJ and associated with chromo-
somal rearrangements and translocations [44, 47–49].
Figure 1. 
The DNA double-strand breaks (DSB) are repaired by the three pathways; these are – A) non-homologous 
end joining (C-NHEJ) which modifies the ends and allow ligation of the broken ends to repair the DSB; B) 
alternate end-joining (alt-EJ of EJ) creates short DNA overhangs with small regions of homology and ligates 
the resected broken ends; and C) homologous recombination (HR) that uses a homologous sequence from sister 
chromatid or homologous chromosome or a homologous sequence within the genome.
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1.3 Homologous recombination requires chromatin remodeling and DDR
To initiate HR (Figure 1C), PARP1 is recruited to the DSB first and immediately 
adds branched PAR groups to itself and histones in close proximity. The branched 
PAR recruit the MRN complex and inactive ATM kinase dimers with the acetyl-
transferase TIP60 attached. PARG quickly removes the PAR groups allowing the 
MRN complex to bind to the DSB. MRN allows ATM to bind at the DSB and activate 
through auto-phosphorylation and acetylation by TIP60, thereby allowing TIP60 to 
dissociate. Once active, ATM will phosphorylate a large number of target proteins 
including the MRN complex and CtIP that process DSB ends [12, 34, 42, 50].
Chromatin remodeling is extensive and required for HR-mediated DSB repair. 
Histone H2AX is phosphorylated by ATM as well as acetylated by TIP60. Phospho-
H2AX (γ-H2AX) has some chromatin remodeling functions and acts as a signal 
to recruit additional proteins involved. γ-H2AX will spread away from the DSB 
to decorate chromatin up to 2 Mb away. MDC1, which assists with chromatin 
remodeling, becomes phosphorylated by ATM and recruits RNF6 dimers that have 
ubiquitination functions. HERC2 associates with phosphorylated RNF6 and appears 
to recruit PIAS4 which has SUMOlyation capabilities. RNF6 becomes SUMOlyated 
and mono-ubiquitinates histones in the area, which recruits RNF168, another 
ubiquitin ligase, that is SUMOlyated and poly-ubiquitinates nearby histones. 
The poly-ubiquitin trees tether BRCA1-A complexes by RAP80 mediators. These 
complexes cause histone modifications that bring in 53BP1, which has more histone 
remodeling functions and can inhibit MRN and CtIP-mediated end resection 
[34, 39, 43, 50].
Phosphorylation of target proteins by ATM also triggers DDR. Chk2 has protein 
kinase activity allowing it to phosphorylate a number of effector proteins in the cell 
cycle checkpoint including p53 which can be modified by either Chk2 or ATM (or 
ATR or Chk1). ARF protein (p14) seems to stabilize TIP60 interactions with ATM 
for better activation and is associated with maintaining genome stability [34].
While the histone remodeling is occurring and other proteins are being 
recruited, MRN and CtIP resect the DSB ends short range end resection, then Exo1 
or Dna2 nucleases act in long range end bidirectional resection in a 5′ to 3′ direc-
tion away from the DSB. Exo1 has dsDNA nuclease function, while Dna2 must act 
with a helicase like BLM or WRN to unwind DNA for its ssDNA nuclease abilities 
[34, 37, 43, 51]. While long range end resection is occurring, RPA binds to the 3’ 
ssDNA overhang to protect from nucleases. After this resection, one type of HR 
can occur called single strand annealing (SSA), where the two pieces of RPA coated 
DNA associate with one another with the help of Rad52 and if regions of homology 
are found they anneal to one another. Non-homologous flaps are cleaved off by 
enzymes like XPF-ERCC1 and ligated by LigaseIII. This type of HR can cause large 
deletions [12, 43, 50, 52].
Canonical HR, as well as break-induced replication (BIR) and synthesis-depen-
dent strand annealing (SDSA) use BRCA 1 and 2 with Rad51 for homology searches 
that cause strand-invasion, D-loop formation and resolution/dissolution. RPA must 
be dissociated from the ssDNA for Rad51 binding, mediated by DSS1 and BRCA2 
which displace RPA and stabilize ATP on Rad51 increasing its binding affinity for 
the ssDNA. Once Rad51 is loaded on the DNA and the nucleofilament has formed, 
it can invade neighboring DNA to search for homology with BRCA1 [34, 43, 50]. 
Homology less than 7 nt in length is a weak interaction and Rad51 not sufficient 
to initiate HR, but 7 nt or longer allows the strand to interact more strongly [50]. 
If significant homology is present, the ATP on Rad51 is hydrolyzed causing the 
dsDNA to dissociate and the nucleofilament anneals with the template strand. 
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RPA stabilizes this D-loop formation by binding to the displaced strand. DNA 
Polymerase δ or ε uses the invading strand as a primer to initiate synthesis [12, 39, 
50, 53]. Resolution can happen with crossover or non-crossover products and differ-
ent sets of resolvases mediate this process. For one-sided ends that utilize BIR, DNA 
Pol δ is used and synthesis continues until the end of the chromosome causing gene 
conversion that can be highly mutagenic [54].
2. Topoisomerase II, inhibitors and poisons
Topisomerase II (Top2) is a regulatory enzyme that relaxes supercoiled DNA 
for transcription (Top2β) and replication (Top2α). As shown in Figure 2, Top2 
acts in a multistep cleavage and religation reaction: (1) Top2 binds to two dsDNA 
molecules at Top2 recognition sequences; (2) a transient DSB is generated in the 
first DNA helix (G-segment) creating a cleavage complex; (3) ATP hydrolysis drives 
a conformational change allowing the second dsDNA helix to pass through the DSB; 
(4) Top2 mediates religation of the DSB and the T DNA segment is released; (5) the 
G DNA segment is released and the enzyme returns to its original conformation 
(Figure 2). A catalytic Top2 inhibitor such as dexrazoxane acts to prevent DNA 
from binding to Top2 at step 1 preventing any part of the catalytic cycle [55–59].
Figure 2. 
Top2 acts in a multistep cleavage and religation reaction. 1) Top2 binds the G and T dsDNA molecules at Top2 
recognition sequences. 2) ATP binding catalyzes the DNA DSB in the G segment, which allows the T segment to 
pass through the break. (3) ATP hydrolysis drives a conformational change allowing the second dsDNA helix to 
pass through the DSB; (4) Top2 mediates religation of the DSB and the T DNA segment is released; (5) the G 
DNA segment is released and the enzyme returns to its original conformation.
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3. Bioflavonoids and other natural compounds as Top2 inhibitors
A class of chemical compounds called bioflavonoids are contained in soy, fruits, 
vegetables, tea, coffee, wine, energy drinks, and dietary supplements [21–27]. 
Bioflavonoids are characterized by multiple phenolic rings that are central to their 
ability to inhibit the enzyme Top2 in a similar manner to the chemotherapeutic drug 
etoposide [16, 28, 29]. Some pesticides and flame retardants also contain multiple 
phenolic rings and have been identified as Top2 inhibitors. Bioflavonoids are sepa-
rated into 12 different sub-classes based upon their structure; however only six are 
contained in dietary sources: flavanols, flavonols, flavones, isoflavones, flavanones, 
and anthocyanidins (Figure 3) [60, 61].
3.1 Isoflavones
Isoflavones are polyphenolic secondary plant metabolites produced through 
the flavonoid-producing phenyl-propanoid synthesis pathway (Figure 4). In order 
for isoflavone production, the plant must express the isoflavone synthase enzyme 
which converts flavanone precursors into isoflavones. This isoflavone synthase is 
only expressed in legumes and a few other select species. Plants with the highest 
concentrations of isoflavones are soy, red clover, and kudzu. The amount of isofla-
vone depends upon the conditions the plants were grown, and the final concentra-
tion of isoflavones in food products (including dietary supplements) depends upon 
which portion of the plant is used and the processing methods. Genistein, daidzein, 
glycitein, formononetin, biochanin A and irilone are the main isoflavones isolated 
Figure 3. 
Basic chemical structures of dietary bioflavonoids. The middle circled backbone represents the general 
bioflavonoid poly-phenol ring structure. The six structures surrounding show the general structural differences 
between the sub-groups.
7
DNA Damage and Repair Mechanisms Triggered by Exposure to Bioflavonoids and Natural…
DOI: http://dx.doi.org/10.5772/intechopen.95453
from plants [60, 62, 63]. Genistein and daidzein are of particular interest due to 
their high concentration in soy products [60]. Genistein is an estrogen derivative 
available at health food stores as dietary and menopausal supplements, and a soy 
phytoestrogen present in foods, particularly soybeans, and infant soy formulas 
[23, 64, 65].
Interest in isoflavones has spiked in the past 20 years. This is due to the attribu-
tion of consumption of isoflavone-containing products with lower occurrences of 
coronary heart disease, breast and prostate cancer. This hypothesis derived from 
observations that citizens of Asian countries have lower incidence of these diseases 
compared to citizens of Western countries, and that citizens in Asian countries typi-
cally ingest 8-50 mg/day of isoflavones compared to citizens in Western countries 
who ingest only 0.1–3.3 mg/day [66, 67] .
Due to this potential health relevance, studies examined the impact of high 
intake of isoflavones, but the results have been inconclusive [62]. In animal models, 
increased genistein intake resulted in increased rates of pituitary and mammary 
gland tumors and stimulated MCF-7 tumor growth. Additionally, while increased 
genistein intake in post-menopausal women in Asian countries decreased breast 
cancer risk, this decreased risk was not sustained in post-menopausal women in 
Western countries, including both native inhabitants and Asian immigrants. Some 
studies, particularly of British women, showed that increased serum genistein levels 
in women with early stage breast cancer had increased transcription of cell cycle 
progression and cell proliferation genes [62].
3.2 Flavones
Flavones are the end product of a complex multi-step synthetic pathway that 
occurs within a wide variety of plants (Figure 4). This pathway begins with phe-
nylalanine that is converted through the generalized phenylpropanoid pathway that 
synthesizes most flavonoids. Subsequently, p-coumaroyl-CoA must be synthesized 
into chalcone with chalcone synthase. Chalcone can be isomerized into a flavanone 
Figure 4. 
Structure of commonly found bioflavonoids flavanols: Genistein and Daidzein, flavonols: Kaemferol quercetin 
and Myricetin, and flavones: Luteolin.
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by chalcone isomerase. Finally, flavone synthase class I or II enzymes catalyze the 
synthesis of a flavone from flavanones. Flavones, similar to flavonols, can protect 
the plant from UV-B radiation. Flavones have the additional ability to provide 
protection against biological attacks from pathogenic microbes by acting as signal-
ing molecules to activate differential gene transcription to prevent the growth of 
microorganisms after invasion. Additionally, flavones can be expressed to deter 
insects and nematodes from eating the plant or to interfere with the growth and 
reproduction of other plants [60].
Flavones are found across a variety of plant species, and expression of flavones 
appears to be widespread within the plant, from the roots to the leaves. However, 
though flavones are found throughout the plant kingdom, they are found much less 
commonly in fruits and vegetables as compared to flavonols. Apigenin and luteolin 
are the main flavonols contained in food sources including celery, parsley, thyme, 
red peppers, and fruit skins [61, 68]. In humans, flavones, much like isoflavones 
and flavonols, seem to have antioxidant and anti-tumor capabilities and to affect 
signal transduction pathways [69].
3.3 Flavonols
Flavonols are primarily in fruits, vegetables, red wine, and tea and they com-
pose the largest portion of humans’ bioflavonoid intake given their distribution 
across a wide number of plant species (Figure 4) [61]. Within plants it has been 
shown that flavonols have the ability to protect the plant against UV-B damage, and 
they protect the plants against oxidative damage with their antioxidant capability 
[70, 71]. Scientists and physicians want to determine ways to utilize the antioxidant 
capability of flavonols in human populations as a protectant against cardiovascular 
and neurological disease and against exercise induced oxidation in smokers and 
athletes [72, 73].
The most common flavonols in foods are quercetin, kaempferol, myricetin, and 
fiestin, with a majority of published literature focusing upon the first three. Similar 
to isoflavones the concentration of flavonol in the food product depends upon the 
plant, the growth conditions, and the part of the plant used. Flavonols are found 
in highest concentrations in the leaves, flowers, and fruits, which are exposed to 
sunlight; the exception to this being onions which grow below ground [70, 71]. The 
human dietary source of flavonols is dependent on culture and region. Humans 
residing in Asian countries typically ingest flavonols through green tea, while the 
Netherlands, United States and Denmark inhabitants mainly ingest them from 
onions, apples, and tea. Citizens of Mediterranean areas ingest flavonols from green 
vegetables. Within Italy, red wine is the main source of flavonols, though inhabit-
ants of Northern villages also have a high intake from salads, soups, fruits. The 
prevalence of flavonols in the human diet has produced a large interest in under-
standing their multiple cellular effects and potential impact on human health [70].
3.4 Additional compounds as Top2 inhibitors
Additional natural compounds other than bioflavonoids may also act as inhibi-
tors of Top2. Bakuchicin from the furanocoumarin family is present in fruits and 
legumes [74]. In research conducted to study DNA-polymerase inhibition activity 
of Psoralea corylifolia L. (Leguminosae), bakuchincin was found to be a weak Top2 
inhibitor [75]. Additional reported naturally occurring Top1 and Top2 inhibitors are 
benzophenone compounds such as xanthochymol and Garcinol at effective concen-
trations comparable to those of etoposide (∼25 − 100 μM) [76, 77]. A comparative 
study between the naturally occurring constituent of black seed thymoquinone 
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used as a spice in eastern cooking and a known Top2 inhibitor 1,4-benzoquinone 
showed structural and functional similarity between the two compounds and the 
ability to induce DNA cleavage [78].
Triterpenoids are present in plants, widely distributed within the root, stem, 
leaves, bark. They are components in the waxy covering of fruits and herbs such 
as jujube, lavender, and thyme [79]. Triterpenoids have two major components, C5 
units and isopentyl diphosphate [80], and are generally present as saponins that act 
as defense chemicals for protection against microbes. Triterpenoids betulin lupane 
and oleanane from the bark of Phyllanthus flexuosus, derivatives of betulinc acid, 
and oxygenated derivatives of oleanane called celastroloids were reported to act 
as human Top2 inhibitors to varying degrees [81–84]. In addition, betulinic acid 
which is an oxidative derivative of betullin inhibits cell proliferation by inhibiting 
topoisomerase-DNA binding and suppressing NF-κB activation [83].
Halogenated compounds in household and baby products include polychlori-
nated biphenyls (PCBs), detectable in indoor carpets, and polybrominated diphe-
nyl ethers (PBDEs), used as flame retardants, increase DNA cleavage by TopIIα in 
vitro and in cultured human cells [85]. Recent CRISPR-Cas9 screening against a 
large panel of genotoxic agents identified the synthetic small molecule pyridostatin 
as a Top2 inhibitor. Pyridostatin is a G-quadruplex stabilizer and this stabilization 
mechanism may lead to Top2 trapping on DNA [38].
4.  Flavonols, flavonols, flavones, isoflavones, flavanones, and 
anthocyanidins act as Top2 poisons and trigger illegitimate DNA 
repair mechanisms
A catalytic Top2 inhibitor such as dexrazoxane acts to prevent DNA from binding 
to Top2 thus preventing any part of the catalytic cycle to occur [55–59]. By contrast, 
some chemicals including bioflavonoids act as Top2 “poisons” (Figure 5) [28, 86]. 
A Top2 poison acts on Top2 after DNA binding and prevents the normal function of 
Top2 (step 2 of catalytic cycle, see Figure 2). Top2 poisons can be further classified 
as covalent or traditional poisons. The potential as a covalent or traditional poison 
is dependent on biochemical structure. These groups are not mutually exclusive and 
individual bioflavonoids can act through one or both mechanisms [29, 86].
4.1 Bioflavonoids as covalent Top2 poisons
Flavanols, flavonols, flavones, flavanones, and anthocyanidins (but not isofla-
vones) have the potential to act as strong covalent Top2 poisons [86]. A covalent 
Top2 poison works in a redox-dependent manner, binding to a distal site on the Top2 
enzyme and increasing its ability to cause a DSB in step 2 of the catalytic multi-step 
reaction through conformational changes to the enzyme. The key structural compo-
nent for a covalent poison is having 3 –OH groups on the B ring of the bioflavonoid 
structure. However, it is likely bioflavonoids with 2 –OH groups on the B ring act as a 
weak covalent poison and the ability to act as a covalent poison increases with more 
–OH groups (Figure 5) [49–50]. A 4’-OH group on the B ring is necessary for binding, 
and 3′ and 5’-OH groups improve covalent binding strength. Thus, a strong covalent 
poison contains 3 –OH groups on the B ring of the bioflavonoid structure. For exam-
ple, among the flavonols, structure predicts that myricetin has high activity, quercetin 
has intermediate activity, and kaempferol has weak activity, if at all, as a covalent 
Top2 poison (Figure 4). Cell free studies support this and show that myricetin as well 
as epigallocatechin-gallate (ECGC) act as strong coalvent poisons, quercetin acts as a 
weak traditional poison, but kaempferol does not have this activity [29, 87].
DNA - Damages and Repair Mechanisms
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4.2 Bioflavonoids as traditional Top2 poisons
Flavones, flavonols, isoflavones, and flavanones (but not flavanols or antho-
cyanidins) have the all act as traditional (or interfacial) Top2 poisons. The key 
structural components for a traditional Top2 poison are a 5’-OH group in the A 
ring, a 4’-OH group in the B ring, and a 4′ = O in the C ring (Figure 5). A tradi-
tional (or interfacial) Top2 poison stalls the enzyme by binding to the active site 
of the enzyme preventing religation, thereby resulting in the formation of a sta-
bilized cleavage complex (SCC) [88, 89]. Flavonols are strong traditional poisons 
and both cell free and cell culture systems support this. Similarly, experiments 
in cell culture systems examining the kinetics of DSB repair following exposure 
to acute doses of bioflavonoids support the model that flavonols, flavones, and 
isoflavones including kaempferol, quercetin, myricetin, genistein, and luteolin 
and each act as a traditional Top2 poison. However, combinatorial activity of 
genistein, quercetin and luteolin together suggests they may have weak covalent 
poisoning capabilities when they have to compete for the traditional poisoning 
binding site [29].
4.3 Bioflavonoids trigger illegitimate DNA repair mechanisms
Bioflavonoids with either covalent and traditional Top2 poisoning activity 
induce the DSB-mediated DDR as evidenced by induction of γ-H2AX foci, ATM 
phosphorylation, and p53 signaling [90–92]. However, a more direct role or 
influence of these compounds on the repair of damage is not as clear [93]. Acute 
doses induce DNA damage and DDR as detected by γ-H2AX foci and phosphory-
lation of ATM in stem cells and CD34+ hematopoietic progenitor cells [94, 95]. 
Figure 5. 
Bioflavonoid classification as a covalent or traditional topoisomerase II poison. The blue boxed regions indicate 
required biochemical features for a traditional Top2 poison. The red 3′, 4′ and 5’-OH groups on the B ring are 
necessary for covalent Top2 poisons. The 4’-OH group is required for covalent binding, while the 3′, 5′ increase 
the binding affinity, therefore a bioflavonoid with all 3-OH groups would be a strong covalent poison.
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Genistein and quercetin inhibit Top2 to induce DNA DSBs, and also appear to 
influence DSB repair pathway choice. Protein level analysis for HR, C-NHEJ, and 
Alt-EJ specific proteins suggests that genistein and quercetin suppress HR by 
reducing BRCA2 and Rad51 expression, as well as suppress C-NHEJ by suppress-
ing levels of DNA-PKcs, Ku80, XLF and XRCC4 and trigger Alt-EJ by increas-
ing levels of CtIP and Polymerase θ [96, 97]. DNA reporter assays suggest that 
quercetin interferes with DNA repair mechanisms such as HR and C-NHEJ by 
inhibition of PI3K/Akt signaling. In support of these studies, exposure to mul-
tiple bioflavonoids promotes the generation of chromosomal translocations in a 
 dose-dependent manner [29, 87].
Bioflavonoids that have traditional Top2 poisoning activity lead to trapped SCCs 
on the DNA. Removal of SCCs is performed by the small ubiquitin-related modifier 
ligase ZNF45/tyrosyl-DNA phosphodiesterase 2 (ZATT/TDP2) complex. Removal 
of the SCC is required for DSB repair by C-NHEJ. If ZATT/TDP2 does not remove 
the SCC, the MRN complex or CtIP with nuclease activity may resect the DNA ends 
with the SCC attached to allow for DSB repair by HR or Alt-EJ [55, 94, 98–101]. 
Inhibition or mutation of multiple DNA repair proteins potentiates cytotoxicity of 
Top2 inhibitors, and MRE11 plays a direct mechanistic role in removal of Top2-DNA 
complexes in yeast and mammals [102, 103].
5. Pleiotropic effects of bioflavonoids
Due to their antioxidant capacity, bioflavonoids are included in dietary supple-
ments for their presumed health benefits in protecting against inflammation, 
cardiovascular diseases, and cancer [87]. These beneficial health properties are due 
to the number of pleiotropic effects bioflavonoids have on cells by impacting signal 
transduction pathways, DSB repair and the cellular epigenetic landscape, which can 
lead to protein level changes, cell cycle stalling, and apoptosis [16, 69].
5.1 Bioflavonoids and signal transduction pathways
Bioflavonoids have antioxidant and anti-inflammatory properties. Their 
antioxidant properties are due to their ability to reduce reactive oxygen species 
of the multiple –OH groups in their chemical structure. Their anti-inflammatory 
properties are due to their interference with signal transduction pathways and 
down-regulation in the production of pro-inflammatory cytokines. Bioflavonoids 
decrease inflammation and immune cell recruitment through interference with the 
ERK/MAP kinase and NF-κB signal transduction pathways which can be beneficial 
to human health. NF-κB is a transcription factor that upon activation is transported 
into the nucleus and binds to the promoter region for a number of cytokines and 
apoptotic genes; therefore reduced pathway activation leads to lower pro-inflam-
matory cytokine production and increased cell survival [104]. Extracts from the 
plant Ginkgo biloba, rich in bioflavonoids, act as an herbal antioxidant, augment the 
transcription of TNF-α causing reduced activation of the NF-κB pathway. Apigenin 
has shown similar down regulatory effects on cytokine production likely through 
the modulation of NF-κB activation [105]. Quercetin and fisetin inhibit pro-
inflammatory cytokine production through the suppression of NF-κB activation by 
decreased phosphorylation of extracellular signal-regulated (ERK) kinase and p38 
mitogen-activated protein (MAP) kinase that are activators of NF-κB [106–108]. 
Myricetin has been shown to affect the phosphatidylinositol 3-kinase (PI3-K) 
pathway inducing apoptosis in pancreatic cells [109].
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5.2 Bioflavonoids and epigenetic modifications
Studies in cancer cell lines demonstrate epigenetic modifications caused by 
bioflavonoids. Genistein, quercetin, curcumin, EGCG, hesperidin, and naringin 
are inhibitors of DNA methyltransferases leading to hypomethylation of DNA. 
In addition, many of these bioflavonoids have also been shown to act on histone 
acetyltransferases and histone deacetyltransferases causing cell wide alterations in 
histone epigenetic modification patterns [109].
Long-term epigenetic effects of bioflavonoids compounds were addressed in sev-
eral mouse model studies. Exposure to genistein through maternal diet during preg-
nancy can have long-lasting effects on the progeny. In agouti mouse pups exposed to 
genistein from conception until birth, epigenetic changes were observed as altered 
coat color, as well as significant downregulation of genes involved in hematopoi-
esis of bone marrow cells, increased erythropoiesis, and a permanent signature 
hypermethylation of repetitive elements in hematopoietic lineages [110]. Likewise, 
in mice exposed to quercetin from conception until birth resulted in upregulated 
iron-associated cytokine expression, significantly increased iron storage in the liver, 
and hypermethylation of repetitive elements. Epigenetic modifications lead to long 
term gene expression changes of cytokines associated with inflammation in the liver 
of the mice in adulthood [111, 112].
6. Implications for human health
6.1 Potential anti-cancer applications
While bioflavonoids can be beneficial through intake at low or moderate doses, 
high doses and acute exposure of bioflavonoids may more drastically inhibit Top2 
and impact genome integrity and cell survival, thus changing their overall impact 
on cells and human health. In vitro studies support the idea that bioflavonoids 
genistein and quercetin may act as chemo-preventive or anti-cancer agents by 
altering major processes within cancer cells such as apoptosis, cell cycle, angiogen-
esis and metastasis [113, 114]. Genistein has synergistic behavior with well-known 
anticancer drugs adriamycin, docetaxel, and tamoxifen, suggesting a potential role 
in combination cancer therapy [78]. Quercetin in combination with doxorubicin 
was found to be more effective in inducing apoptosis within the SKOV-3 cells [114]. 
A combinatory treatment with quercetin and curcumin synergistically induce anti-
cancer activity in triple-negative breast cancer cells by modulating tumor suppres-
sor genes in particular enhancing BRCA1 expression [115].
Several bioflavonoids have been investigated as alternate cancer therapeutics 
that are less genotoxic than traditional chemotherapeutics but equally effective. 
High concentrations of myricetin causes Top2-mediated DNA damage and apop-
tosis in K652 cells [116]. Fisetin interrupts the MAPK-dependent NF-κB signaling 
pathway in cervical cancer cells, inhibiting migration and invasion [114]. Several 
in vitro and in vivo studies indicate that luteolin can suppress metastasis of breast 
cancer by reversing epithelial-mesenchymal transition, or by acting as an antiangio-
genic therapeutic inhibiting VEGF production and suppressing invasion [117, 118].
While these observations strengthen the notion that flavonoids could be useful 
anti-cancer agents, to date minimal clinical studies have demonstrated that these 
bioflavonoids retain anti-cancer properties in humans in vivo. A Phase I study/
pharmacokinetic trial of quercetin in cancer patients intravenously injected quer-
cetin in 11 patients with cancer at varying doses of 60–2000 mg/m2 and identified 
945 mg/m2 as a safe and effective dose [119].
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6.2 Potential inducers of infant leukemia
Aberrant repair of DNA DSBs caused by either endogenous or exogenous agents 
has the potential to result in DNA sequence mutations or genome rearrangements 
such as chromosomal translocations which can lead to disease. Negative conse-
quences of high bioflavonoid intake can be observed most prominently in pregnant 
women. Epidemiological data from countries whose citizens have higher bioflavo-
noid intake (particularly soy products) had a 2–3 times higher incidence of infant 
leukemia, characterized by chromosomal translocation, suggesting maternal intake 
of high amounts of bioflavonoids could lead to this particular genome rearrange-
ment and infant leukemia [120].
Infant leukemia typically occurs due to translocation events involving the mixed 
lineage leukemia (MLL) gene. Most of the MLL rearrangements observed in patients 
with infant leukemia and therapy-related leukemia (tAML) cluster together in a 
well-defined region of the MLL locus [121]. tAML is associated with treatment with 
Top2 poisons etoposide or doxorubicin [86, 88, 121] which has led to the hypothesis 
and working model that ingestion of natural Top2 poisons including bioflavonoids 
can lead to these translocation events and tumorigenesis [121, 122]. In support of 
this, boflavonoids have been shown to inhibit Top2 and induce MLL cleavage and 
translocations in hematopoietic stem cell-enriched populations [87, 121].
Foods contain multiple different bioflavonoids, and bioflavonoids are bio-
accumulative which likely increases plasma concentrations [123]. Study of the 
potential for environmental or dietary compounds to induce infant leukemias is 
more relevant since they cross the placental barrier as shown with the synthetic 
bioflavonoid EMD-49209 [124], genistein [111, 125], quercetin [111], herbal 
medicines, dipyrone, and pesticides including the mosquitocidal Baygon [126, 127]. 
Genotoxic effects of quercetin on the human hemopoietic stem and progenitor cells 
(HSPCs) were shown using a genetically engineered placental barrier model from a 
specialized human cell line. This study showed that approximately 10% of quercetin 
from the maternal side is capable of crossing the placental barrier and accumulating 
in the fetus. Exposure in utero is likely more damaging due to differences in meta-
bolic and excretion rates of mother and fetus [128] as well as rapidly developing and 
proliferating fetal cells that are more sensitive to Top2 inhibiting agents [129].
7. Conclusion
Bioflavonoids are prevalent in the human diet from natural sources such as 
fruits and vegetables, but are also found at supranatural concentrations in dietary 
supplements and energy drinks. These chemical compounds have numerous cellular 
effects including interfering with signal transduction pathways, modifying the 
DNA damage response and epigenetic markers, and poisoning of Top2 causing 
DNA DSBs and leading to aberrant repair. Given the number of cellular pathways 
bioflavonoids affect, and the DNA damage caused by bioflavonoid exposure, it is 
possible that bioflavonoids could be used as natural analogs of traditional chemo-
therapeutic agents. However, more research is needed to understand how these bio-
flavonoids cause DNA damage through Top2-dependent or -independent pathways 
to understand potential off-target negative effects. In addition, further research 
will be needed to understand the dose-dependent activities of bioflavonoids and 
at what doses they may be chemo-protective versus what threshold doses they may 
induce DNA damage that is mutagenic, and finally at what high acute doses they 
may induce DNA damage and apoptosis to act as effective alternative to traditional 
chemotherapeutic agents.
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